http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2009113038-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
filingDate 2009-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2010-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2009113038-A
titleOfInvention COMBINED MEDICINE THERAPY FOR TREATMENT OF OBESITY
abstract 1. A method of treating obesity, comprising administering to a subject in need thereof an effective amount of a combination of galantamine and a selective serotonin reabsorption inhibitor (SSRI) without administering anorexicant, whereby obesity is treated. ! 2. The method according to claim 1, where these selective serotonin reabsorption inhibitors (SSRIs) are selective serotonin reabsorption inhibitors selected from the group consisting of citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline and mixtures thereof. ! 3. The method according to claim 1, where the specified combination contains effective amounts of galantamine and sertraline. ! 4. The method according to claim 1, where the specified galantamine is administered in an amount of 4 mg per dose,! 5. The method according to claim 1, where the specified galantamine and the specified SSRI is administered once a day. ! 6. The method according to claim 1, where the specified galantamine and the specified SSRI is administered simultaneously. ! 7. The method according to claim 1, where the specified combination is introduced into the composition with controlled release. ! 8. The method according to claim 1, where the specified galantamine and the specified SSRI is administered at different times. ! 9. The method of claim 1, wherein said subject loses at least about 15 pounds after about 70 days of treatment. ! 10. The method of claim 1, wherein said subject loses at least about 20 pounds after about 100 days of treatment. ! 11. A method of achieving the desired weight loss, comprising administering to a subject in need thereof an effective amount of a combination of galantamine and one or more SSRIs without administering an anorexic, whereby said subject loses the desired amount of weight. ! 12. The method according to claim 11, where the specified subject is overweight. !13. The method according to claim 11, where indicated
priorityDate 2003-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501289
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5361192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2771
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68617
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9651
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493337
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507269
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID43815
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419475708
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3386

Total number of triples: 44.